Schedule 13D ownership disclosure

AKOUSTIS TECHNOLOGIES INC

Common Stock, $0.0001 par value per share · CUSIP: 00973N102

Event date: 2026-01-12

Filing-level shares
6,344,114.00
Percent of class
11.9%
  • Eli Lilly and CompanyReported CIK 0000059478

    Shares: 6,344,114.00 · Class: 11.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-013469
Form type
SCHEDULE 13D
Filer
Aktis Oncology, Inc.
CIK
CIK 2035832
Filed
Jan 15, 2026
Reporting period
Jan 12, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub